Cited by 262Thyroid Disorders and TreatmentsThyroid and Parathyroid SurgeryPregnancy and Medication Impact

Thyroid hormone early adjustment in pregnancy (the THERAPY) trial

Yassa, Leila, Marqusee, Ellen, Fawcett, Rachael, Alexander, Erik K.·2010·The Journal of Clinical Endocrinology & Metabolism

Abstract

BACKGROUND: Thyroid hormone requirement increases 20-40% during gestation. Women with treated hypothyroidism must increase their l-T(4) in pregnancy to prevent maternal hypothyroidism, although how this should be accomplished is unclear. METHODS: We prospectively enrolled 60 women with treated hypothyroidism seeking pregnancy. Once pregnant, women were randomized to increase l-T(4) by either two tablets/wk (group A) or three tablets/wk (group B). Thyroid function was tested biweekly through midpregnancy and at 30 wk gestation. Levothyroxine was adjusted to maintain goal TSH concentrations. The primary objective was to assess efficacy in preventing maternal hypothyroidism and the safety of this intervention. RESULTS: Forty-eight women completed the protocol. Increasing the l-T(4) dose once pregnant (regardless of study arm) prevented TSH elevation over 5.0 mIU/liter throughout the first trimester and replicated physiological changes of pregnancy. The early l-T(4) increase caused TSH suppression below 0.5 mIU/liter in eight of 25 women in group A compared with 15 of 23 women in group B (P < 0.01). This risk was significantly increased in athyreotic patients [odds ratio (OR) = 3.3; 95% confidence interval (CI) = 1.1-11.1], those with prepregnancy TSH less than 1.5 mIU/liter (OR = 4.6; 1.3-16.2), and those receiving prepregnancy l-T(4) doses of 100 microg/d or more (OR = 7.2; 1.7-30.6). However, if a trimester-specific TSH lower reference range of 0.1 mIU/liter was used, only two patients (8%) in group A required dose reduction. TSH testing every 4 wk identifies 92% of abnormal values. CONCLUSIONS: A two-tablet increase in l-T(4) initiated at confirmation of pregnancy significantly reduces the risk of maternal hypothyroidism during the first trimester and mimics normal physiology. Monitoring TSH every 4 wk through midgestation is recommended.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1210/jc.2010-0013

Cites

24 of 24 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 1

  1. Fritz MA 2005 Epidemiology of pregnancy loss. In: Speroff L, Fritz M, eds. Clinical gynecologic endocrinology and infertility. 7th ed. Philadelphia: Lippincott, Williams, Wilkins; 1070 -1107

Cited by

Sorted by citations

Authors
Yassa, L., Marqusee, E., Fawcett, R., & Alexander, E. K.
Affiliations
Brigham and Women's Hospital (US)
Corresponding author
Alexander, Erik K.
Venue
The Journal of Clinical Endocrinology & Metabolism
Published
2010-07-01
Volume
95
Issue
7
Pages
3234-3241
ISSN
  • 0021-972X (ISSN-L)
  • 1945-7197
OpenAlex
W2118914879
Cited by
262
References
24
Citations by year
2026: 7 · 2025: 8 · 2024: 9 · 2023: 9 · 2022: 15 · 2021: 15 · 2020: 10 · 2019: 17 · 2018: 6 · 2017: 67 · 2016: 13 · 2015: 15 · 2014: 20 · 2013: 13 · 2012: 15
FWCI
11.78
Type
journal article
Language
en
Open access
closed
Locations
  • The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Disorders and Treatments
  • Health Sciences › Medicine › Surgery › Thyroid and Parathyroid Surgery
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Pregnancy and Medication Impact
Keywords
levothyroxine, pregnancy, TSH suppression, first trimester, thyroid function monitoring, athyroidism, dose escalation
MeSH terms
Adult, Drug Administration Schedule, Female, Humans, Hypothyroidism, Pregnancy, Pregnancy Complications, Thyrotropin, Thyroxine

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review